Menarini Group Presented Initial Safety and Efficacy Data from Phase 1b/2 ELEVATE and ELECTRA Combin

ELEVATE and ELECTRA studies were designed with the objective to overcome different treatment resistance mechanisms and enhance patient outcomes with oral-oral combination options.A preliminary analysis of data in the phase 1b part of the ELEVATE trial demonstrates antitumor activity of the combination evaluating ORS...

Related Keywords

United States ,Italy ,Elcin Barker Ergun ,Cheya Pope ,Valeria Speroni Cardi ,Menarini Group ,Elacestrant Clinical Development Program ,Menarini Group Stemline Therapeutic ,Stemline Therapeutics Inc ,Division Of Hematology ,Stemline Therapeutics ,Antonio Breast Cancer Symposium ,Hope Rugo ,Stemline Therapeutic ,Fetal Toxicity ,